Legend Biotech

Forecast & Rating13 analysts currently cover Legend Biotech, with about 61.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $45.62, about 95.0% upside from the current price of $23.40. Price targets range from $24.00 to $68.00 — a wide spread, showing clear disagreement over just how much Legend Biotech can rise. Historically, about 51.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Legend Biotech closely still see room for the stock to rise. Data as of Oct 26, 2026; for reference only and not investment advice.